results

FREE subscriptions for doctors and students... click here
You have 3 more open access pages.

Treatment with ramipril resulted in the following risk reductions:

  • 25% (p=0.0004) for combined primary outcome
  • 22% for MI
  • 33% for stroke
  • 37% for cardiovascular death
  • 17% revascularisation
  • 24% (p=0.027) for overt nephropathy

Last reviewed 01/2018